Medicine

All Articles

Helicobacter pylori, stomach cancer and the assessment dilemma

.Attribute Medication, Published online: 17 Oct 2024 doi:10.1038/ d41591-024-00075-5A large research...

Health artificial intelligence needs meaningful human involvement: trainings coming from war

.Artificial intelligence (AI) remains to reveal its ability for technology in health care. As this i...

Systems education may teach the newest generation of scientists and also specialists

.In recent years, there has been actually growing problem about winding down passion in scientific r...

How to prepare for the following inescapable Ebola outbreak: lessons from West Africa

.Ministry of Health And Wellness, Kampala, UgandaHenry Kyobe Bosa, u00c2 Misaki Wayengera, u00c2 Hen...

Perioperative immunotherapy for sac cancer cells

.STUDY HIGHLIGHT.16 October 2024.

In the NIAGARA trial, the addition of perioperative durvalumab ...

A chatbot modifies the minds of conspiracy theorists

.RESEARCH STUDY EMPHASIZE.14 Oct 2024.

A research of over 2,000 individuals presents that connect...

How to form cardiology medical trials a lot more comprehensive #.\n\nVilcant, V., Ceron, C., Verma, G., Zeltser, R. &amp Makaryus, A. N. Inclusion of under-represented ethnological and nationalities in heart scientific trials. Cardiovascular System Lung Circ. 31, 1263\u00e2 $\" 1268 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nFilbey, L. et cetera. Improving representativeness in trials: a phone call to activity from the International Cardiovascular Scientific Trialists Online Forum. Eur. Center J. 44, 921\u00e2 $\" 930 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nJin, X. et cetera. Women\u00e2 $ s engagement in cardio clinical tests coming from 2010 to 2017. Blood circulation 141, 540\u00e2 $\" 548 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nCholesterol Levels Therapy Trialists\u00e2 $ Cooperation Efficacy and security of statin treatment in more mature folks: a meta-analysis of specific participant data coming from 28 randomised regulated tests. Lancet 393, 407\u00e2 $\" 415 (2019 ). Au, M. et cetera. A systematic review of sex-specific reporting in cardiac arrest professional trials: test circulation as well as results. J. Am. Coll. Cardiol. Adv. 1, 100079 (2022 ).\nGoogle.com Scholar\u00c2.\nWei, S. et al. Aspects related to genetic and also ethnic range one of cardiac arrest test participants: a step-by-step bibliometric testimonial. Circ. Heart Fail. 15, e008685 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nTahhan, A. S. et al. Application of much older people, girls, as well as racial\/ethnic adolescence groups in present-day severe coronary syndrome scientific tests: a systematic review. JAMA Cardiol. 5, 714\u00e2 $\" 722 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nCherubini, A. et al. The relentless exemption of more mature individuals from continuous medical tests relating to cardiac arrest. Arc. Trainee. Medication. 171, 550\u00e2 $\" 556 (2011 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nMichos, E. D. &amp Truck Spall, H. G. C. Boosting representation as well as range in cardio medical trial populaces. Nat. Rev. Cardiol. 18, 537\u00e2 $\" 538 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNational Academies of Sciences, Engineering, as well as Medicine. Improving Representation in Medical Tests as well as Research: Structure Study Equity for Female and also Underrepresented Groups (eds Bibbins-Domingo, K. &amp Helman, A.) (National Academies Press, 2022). Packer, M. et al. Cardiovascular and renal end results along with empagliflozin in cardiac arrest. N. Engl. J. Medication. 383, 1413\u00e2 $\" 1424 (2020 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nZannad, F. et al. SGLT2 inhibitors in individuals with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and also DAPA-HF trials. Lancet 396, 819\u00e2 $\" 829 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nLam, C. S. P. et al. Regional as well as indigenous influences on the action to empagliflozin in patients along with cardiac arrest as well as a lessened ejection portion: the EMPEROR-Reduced test. Eur. Center J. 42, 4442\u00e2 $\" 4451 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nRathore, S. S., Wang, Y. &amp Krumholz, H. M. Sex-based distinctions in the effect of digoxin for the therapy of heart failure. N. Engl. J. Med. 347, 1403\u00e2 $\" 1411 (2002 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nMihan, A., Pandey, A. &amp Truck Spall, H. G. C. Reducing the risk of artificial intelligence predisposition in cardio care. Lancet Digit. Wellness https:\/\/doi.org\/10.1016\/S2589-7500( 24 )00155-9 (2024 ). Bodicoat, D. H. et cetera. Advertising incorporation in medical trials\u00e2 $\" a rapid review of the literary works as well as suggestions for action. Tests 22, 880 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGoldberg, E. M. et cetera. Making use of social networks for professional research: referrals and instances coming from the Brown-Lifespan Center for Digital Health And Wellness. J. Med. World wide web Res. 24, e35804 (2022 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nMihan, A. &amp Truck Spall, H. G. C. Interventions to enrich electronic health and wellness equity in cardiovascular treatment. Nat. Med. 30, 628\u00e2 $\" 630 (2024 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nFultinavi\u00c4 i\u00c5\" t\u00c4 --, U. AI benefits in person identification and clinical trial recruitment possesses obstacles in sight. Scientific Tests Arena https:\/\/www.clinicaltrialsarena.com\/features\/ai-clinical-trial-recruitment\/ (2022 ). Grover, N. &amp Coulter, M. Idea: major pharma bets on AI to accelerate scientific trials. Wire service https:\/\/www.reuters.com\/technology\/big-pharma-bets-ai-speed-up-clinical-trials-2023-09-22\/ (2023 ). Kretschmer, M., Kretschmer, T., Peukert, A. &amp Peukert, C. The dangers of risk-based AI guideline: taking liability seriously. SSRN https:\/\/doi.org\/10.2139\/ssrn.4622405 (2023 ). Strumberger, S. EU AI Action: the most up to date updates on the world\u00e2 $ s first complete AI requirement legislations. Thomson Wire service https:\/\/legalsolutions.thomsonreuters.co.uk\/blog\/2023\/12\/12\/ai-act-the-worlds-first-comprehensive-laws-to-regulate-ai\/

:~:text=In%20April%202021%2C%20the%20European,mean%20more%20or%20less%20regulation (2024 ). Ali, M. ...

To conquer antimicrobial resistance in Africa, develop regional capacity

.Boosts in antimicrobial resistance around the globe are probably to strike African countries the ha...

Lessons from a negative genetics therapy trial for Duchenne muscle dystrophy

.Attributes Medicine, Published online: 09 Oct 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene m...

People with cardiac pacemakers require multidisciplinary treatment

.Nature Medicine, Released online: 09 October 2024 doi:10.1038/ s41591-024-03296-wEchocardiographic ...